MCID: NNS012
MIFTS: 10

Non-Small Cell Lung Cancer, Childhood

Categories: Rare diseases, Respiratory diseases, Cancer diseases

Aliases & Classifications for Non-Small Cell Lung Cancer, Childhood

MalaCards integrated aliases for Non-Small Cell Lung Cancer, Childhood:

Name: Non-Small Cell Lung Cancer, Childhood 50

Classifications:



Summaries for Non-Small Cell Lung Cancer, Childhood

MalaCards based summary : Non-Small Cell Lung Cancer, Childhood The drugs Indinavir and Ritonavir have been mentioned in the context of this disorder. Affiliated tissues include lung, liver and brain.

Related Diseases for Non-Small Cell Lung Cancer, Childhood

Symptoms & Phenotypes for Non-Small Cell Lung Cancer, Childhood

Drugs & Therapeutics for Non-Small Cell Lung Cancer, Childhood

Drugs for Non-Small Cell Lung Cancer, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Indinavir Approved Phase 2 150378-17-9 5362440
2
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
3
Docetaxel Approved May 1996, Investigational Phase 1, Phase 2 114977-28-5 148124 9877265
4 Anti-HIV Agents Phase 2
5 Anti-Infective Agents Phase 2
6 Anti-Retroviral Agents Phase 2
7 Antiviral Agents Phase 2
8 Cytochrome P-450 CYP3A Inhibitors Phase 2
9 Cytochrome P-450 Enzyme Inhibitors Phase 2
10 HIV Protease Inhibitors Phase 2
11 Liver Extracts Phase 2,Phase 1
12
protease inhibitors Phase 2
13 Androgens Phase 1, Phase 2
14 Cola Nutraceutical Phase 2,Phase 1
15 Analgesics Phase 1
16 Analgesics, Non-Narcotic Phase 1
17 Interleukin-2 Phase 1
18 Peripheral Nervous System Agents Phase 1
19 Vaccines Phase 1
20
Cyclophosphamide Approved, Investigational 50-18-0, 6055-19-2 2907
21
Dimenhydrinate Approved 523-87-5 441281
22
Ethanol Approved 64-17-5 702
23
Hydrogen peroxide Approved, Vet_approved 7722-84-1 784
24 Alkylating Agents
25 Antirheumatic Agents
26 Immunosuppressive Agents
27 Antibodies
28 Immunoglobulins
29 Pharmaceutical Solutions

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
2 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
3 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
4 Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Completed NCT00161187 Phase 1
5 Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Unknown status NCT00499733 cyclophosphamide
6 OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Completed NCT00900302

Search NIH Clinical Center for Non-Small Cell Lung Cancer, Childhood

Genetic Tests for Non-Small Cell Lung Cancer, Childhood

Anatomical Context for Non-Small Cell Lung Cancer, Childhood

MalaCards organs/tissues related to Non-Small Cell Lung Cancer, Childhood:

39
Lung, Liver, Brain, Lymph Node

Publications for Non-Small Cell Lung Cancer, Childhood

Variations for Non-Small Cell Lung Cancer, Childhood

Expression for Non-Small Cell Lung Cancer, Childhood

Search GEO for disease gene expression data for Non-Small Cell Lung Cancer, Childhood.

Pathways for Non-Small Cell Lung Cancer, Childhood

GO Terms for Non-Small Cell Lung Cancer, Childhood

Sources for Non-Small Cell Lung Cancer, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....